Transfusion practices for patients with sickle cell disease at a major academic medical center

Immunohematology

Volumn 22, Issue 3, 2006, Pages 103-107

  Afenyi Annan, A ^a   Bandarenko, N ^a  

^a UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD BANK; BLOOD GROUP TYPING; CLINICAL PRACTICE; CLINICAL PROTOCOL; ERYTHROCYTE TRANSFUSION; HUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SEROLOGY; SICKLE CELL ANEMIA; UNITED STATES; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ANEMIA, SICKLE CELL; BLOOD BANKS; BLOOD GROUPING AND CROSSMATCHING; BLOOD TRANSFUSION; HUMANS;

EID: 33750435226     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. National Institutes of Health, National Heart, Lung, and Blood Institute. Management of sickle cell disease. 4th ed. Washington, DC: National Institutes of Health; 2002. NIH publication 02-2117. http://www.nhlbi.nih.gov/health/prof/ blood/sickle/sc_mngt.pdf.
2. Adams, RJ, McKie VC, Carl EM, et al. Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann of Neurol 1997;42:699-704.
3. Adams, RJ, McKie VC, Hsu L, et al. Prevention of first stroke by transfusion in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5-11.
4. Adams RJ, Brambilla D; for the optimizing primary stroke prevention in sickle cell anemia (STOP 2) trial investigators. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 2005;353:2769-78.
5. Ohene-Frempong K. Indications for red cell transfusion in sickle cell disease. Semin in Hematol 2001;38(Suppl 1):5-13.
6. Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990;322:1617-21.
7. Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease. Blood 1990;76:1431-7.
8. Orlina A, Sosler SD, Koshy M. Problems of chronic transfusion in sickle cell disease. J Clin Apher 1991;6:234-240.
9. Ambruso DR, Githens JH, Alcorn R, et al. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy. Transfusion 1987;27:94-8.
10. Afenyi-Annan A, Lottenberg R, Konrad TR. Blood bank practices for sickle cell patients in North Carolina (abstract). Transfusion 2004;44(Suppl 9):135.
11. Afenyi-Annan A, Brecher M. Pre-transfusion phenotype matching for sickle cell patients (letter). Transfusion 2004;44:619-20.
12. Mallory D, Malamut D, Sandler SG. A decade of rare donor services in the United States. Vox Sang 1992;63:186-91.
13. American Red Cross. "CIAA Increase Minority Blood and Bone Marrow Donations." Available at: http://www.redcross.org/article/0,1072,0_332_23 17,00.html. Accessed March 5, 2004.
14. Afenyi-Annan A, Parrish T African American blood donors at a local historically black college/university (abstract). Transfusion 2004;44(Suppl 9):183-18.